News and Announcements
MHRA Approves Commencement of OncoSil’s Study of Pancreatic Cancer Clinical Study in UK
- Published February 21, 2017 11:32AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
OncoSil Medical Limited (ASX:OSL) is a medical device company seeking to advance radiation for cancer patients.
KEY TAKEAWAYS:
- Medical device company is mainly focused on localised treatments for patients with pancreatic and liver cancer.
- MHRA has approved the commencement of the Pancreatic Cancer Clinical Study in the UK.
OncoSil Medical Limited is a clinical-stage Australian Lifesciences company with the aim to develop and provide technologies for safer medical radiation treatments.
“The comprehensive MHRA review conducted over the past two months, focused on pre-clinical, clinical data as well study design. Approval was granted with no objections raised.
Daniel Kenny, CEO commented:
We are delighted with this news, which is a further endorsement of our clinical data package and allows OncoSil Medical to commence Clinical Studies in the UK.”
OncoSil Medical hopes with treatment of OncoSil™ it will deliver a more concentrated localised beta radiation compared to external beam radiation. OncoSil Medical has conducted four clinical studies with encouraging results on tolerability, safety and efficacy.
To view the full ASX Announcement, please click here.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
